| Marie C Smith, MD, | |
|
400 Highland Ave, Lewistown, PA 17044-1167 | |
| (717) 242-4200 | |
| (717) 242-4212 |
| Full Name | Marie C Smith |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 30 Years |
| Location | 400 Highland Ave, Lewistown, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104827807 | NPI | - | NPPES |
| 301676 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 30167 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Geisinger-lewistown Hospital | Lewistown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Geisinger Clinic | 5395657001 | 2866 |
News Archive
Increasing diabetes awareness and integrating a multi-faceted, approach to improve patient care and education, results in significantly improved patient outcomes, according to a report in the April issue of Clinical Diabetes, a publication of the American Diabetes Association.
Today the EU project, TECHGENE, that focuses on developing Next Generation Sequencing (NGS) diagnostic tools for genetic disorders, announced that CLC bio has been selected as the software partner for this project.
News outlets are focusing on the stories of individual consumers to explain how health care reform legislation may affect the lives and health of people around the nation.
The drug rimonabant was developed as a treatment for obesity and its myriad of serious health consequences. Despite having its desired effects on weight, which it decreased, and on levels of glucose and fats in the blood, rimonabant was never approved for use in the US because of serious neurological side effects including depression and anxiety. Now, a team of researchers, led by George Kunos, at the National Institutes of Health, Bethesda, and Alexandros Makriyannis, at Northeastern University, Boston, have developed a drug that has the same positive effects in mice on levels of glucose and fats in the blood as rimonabant but none of the neurological side effects.
› Verified 7 days ago
| Entity Name | Geisinger Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
Increasing diabetes awareness and integrating a multi-faceted, approach to improve patient care and education, results in significantly improved patient outcomes, according to a report in the April issue of Clinical Diabetes, a publication of the American Diabetes Association.
Today the EU project, TECHGENE, that focuses on developing Next Generation Sequencing (NGS) diagnostic tools for genetic disorders, announced that CLC bio has been selected as the software partner for this project.
News outlets are focusing on the stories of individual consumers to explain how health care reform legislation may affect the lives and health of people around the nation.
The drug rimonabant was developed as a treatment for obesity and its myriad of serious health consequences. Despite having its desired effects on weight, which it decreased, and on levels of glucose and fats in the blood, rimonabant was never approved for use in the US because of serious neurological side effects including depression and anxiety. Now, a team of researchers, led by George Kunos, at the National Institutes of Health, Bethesda, and Alexandros Makriyannis, at Northeastern University, Boston, have developed a drug that has the same positive effects in mice on levels of glucose and fats in the blood as rimonabant but none of the neurological side effects.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marie C Smith, MD, 100 N Academy Ave, Danville, PA 17822-4903 Ph: (570) 271-6144 | Marie C Smith, MD, 400 Highland Ave, Lewistown, PA 17044-1167 Ph: (717) 242-4200 |
News Archive
Increasing diabetes awareness and integrating a multi-faceted, approach to improve patient care and education, results in significantly improved patient outcomes, according to a report in the April issue of Clinical Diabetes, a publication of the American Diabetes Association.
Today the EU project, TECHGENE, that focuses on developing Next Generation Sequencing (NGS) diagnostic tools for genetic disorders, announced that CLC bio has been selected as the software partner for this project.
News outlets are focusing on the stories of individual consumers to explain how health care reform legislation may affect the lives and health of people around the nation.
The drug rimonabant was developed as a treatment for obesity and its myriad of serious health consequences. Despite having its desired effects on weight, which it decreased, and on levels of glucose and fats in the blood, rimonabant was never approved for use in the US because of serious neurological side effects including depression and anxiety. Now, a team of researchers, led by George Kunos, at the National Institutes of Health, Bethesda, and Alexandros Makriyannis, at Northeastern University, Boston, have developed a drug that has the same positive effects in mice on levels of glucose and fats in the blood as rimonabant but none of the neurological side effects.
› Verified 7 days ago
Dr. Sarah Beth Scott, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 400 Highland Ave, Lewistown, PA 17044 Phone: 717-248-5411 | |
Dr. Olamide Kolade, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 400 Highland Ave, Lewistown, PA 17044 Phone: 717-248-5411 Fax: 717-242-4212 | |
Shashpal K Malhotra, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 18 N Main St, Lewistown, PA 17044 Phone: 717-242-1441 Fax: 701-242-6107 | |
Rajeshwar P Malhotra, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 18 N Main St, Lewistown, PA 17044 Phone: 717-242-1441 Fax: 717-242-6107 |